3C-DFE
Overview[edit | edit source]
3C-DFE, also known as 3-Chloro-3-deoxyfluoroephedrine, is a synthetic compound that belongs to the class of ephedrine derivatives. It is characterized by the presence of a chlorine atom and a fluorine atom in its molecular structure, which distinguishes it from other ephedrine analogs.
Chemical Properties[edit | edit source]
3C-DFE is a chiral compound, meaning it has a specific three-dimensional arrangement that can exist in different stereoisomers. The presence of the chlorine and fluorine atoms in its structure can influence its pharmacokinetics and pharmacodynamics.
Mechanism of Action[edit | edit source]
As an ephedrine derivative, 3C-DFE is believed to act primarily as a sympathomimetic agent. It stimulates the release of norepinephrine and dopamine from nerve endings, leading to increased adrenergic receptor activity. This results in effects such as increased heart rate, bronchodilation, and vasoconstriction.
Clinical Applications[edit | edit source]
Currently, 3C-DFE is primarily used in research settings to study its effects on the central nervous system and its potential therapeutic applications. Its structural modifications may offer insights into the development of new drugs with improved efficacy and reduced side effects compared to traditional ephedrine.
Safety and Toxicology[edit | edit source]
The safety profile of 3C-DFE is not well-established, as it is not widely used in clinical practice. However, as with other sympathomimetic agents, potential side effects may include hypertension, tachycardia, and anxiety. Further studies are needed to fully understand its toxicological properties.
Related Compounds[edit | edit source]
3C-DFE is related to other ephedrine derivatives such as pseudoephedrine, methamphetamine, and phenylpropanolamine. These compounds share similar mechanisms of action but differ in their chemical structures and clinical uses.
Research Directions[edit | edit source]
Ongoing research is focused on exploring the potential of 3C-DFE in treating conditions such as asthma, narcolepsy, and obesity. Its unique chemical structure may offer advantages over existing treatments, but more studies are needed to confirm its efficacy and safety.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
